Sage Journals: Discover world-class research

Abstract

Objective

Identify predictors of overall survival (OS) after hypopharyngeal/laryngeal cancer in Florida.

Material and Methods

We conducted a retrospective cohort study using data from the Florida Cancer Data System (FCDS) on patients diagnosed with hypopharyngeal or laryngeal cancer from 2010-2017. Primary outcome was OS. Hazard ratios (HRs) were estimated from univariable and multivariable Cox regression models for OS. Data was analyzed from November 1, 2022, to June 30, 2023.

Results

We analyzed 6771 patients, who were primarily male (81.2%), White non-Hispanic (WNH) (78.2%), publicly insured (70.1%), married (51.8%), and residents of urban counties (73.6%). Black patients were more likely to be younger at diagnosis (38.9%), single (43.4%), to have distant SEER stage disease (25.6%). Median OS were lowest among patients who were uninsured (34 months), with hypopharyngeal site disease (18 months), and a smoking history (current: 34 months, former: 46 months, no smoking: 63 months). Multivariable Cox regression analysis showed worse OS for single/unmarried vs married (HR 1.47 [95%CI: 1.36-1.59], P < .001), history of tobacco use (current: HR 1.62 [95%CI: 1.440-1.817], P < .001; former smokers: (HR 1.28 [95%CI: 1.139-1.437], P < .001) vs no history). Improved OS was observed among White Hispanics (WH) vs WNH (HR .73 [95%CI: .655-.817], P < .001) and women vs men (HR .88 [95%CI: .807-.954], P = .002). Geographical mapping showed that mortality rates were highest in census tracts with low income and education.

Conclusion

Our findings suggest that sociodemographic and clinical factors impact OS from hypopharyngeal/laryngeal cancer in Florida and vary geographically within the state. These results will help guide future public health interventions.

Keywords

laryngeal cancer hypopharyngeal cancer epidemiology

Introduction

Laryngeal carcinoma accounted for approximately 12 380 new cases and 3820 deaths in the United States in 2023.¹ Hypopharyngeal malignancies are less common, with approximately 2500 new cases annually.²

Although laryngeal and hypopharyngeal cancer are distinct diseases, they are often grouped together in medical literature due to close proximity, shared risk factors, and similar treatment approaches.³ Squamous cell carcinomas (SCC) account for about 95% of laryngeal and hypopharyngeal malignancies.² These cancers are most common in men between the fifth or sixth decades of life.⁴ Currently, these malignancies are primarily managed with a combination of surgery, radiation, and chemotherapy. Hypopharyngeal malignancies are associated with higher morbidity and mortality due to a lack of early specific symptoms.⁵

Disparities in survival rates based on race/ethnicity and sociodemographic factors are well-documented in literature for patients with laryngeal cancer.⁶ Disparities among patients with hypopharyngeal SCC is less well documented. A Surveillance, Epidemiology, and End Results (SEER) database study by Divakar et al⁷ noted that laryngeal cancer mortality rate did not improve in a similar manner to the incidence rate, citing potential factors such as advanced disease at presentation, differences in health care access, treatment delays, and changes in referral patterns.

Patterns of mortality from cancer are geographically diverse. Mokdad et al⁸ found that the age−standardized county-level head and neck cancer (HNC) mortality rates in the southern United States (US) were higher than other regions in the US from 1980 to 2014. Another study highlighted divergent trends within the southern US, showing that from 1990-2017, laryngeal cancer mortality in Florida declined by 9.5%, whereas in Mississippi, it increased by 12.8%.⁹

To reduce deaths related to laryngeal and hypopharyngeal cancer, we must examine disparities in the distribution of risk factors at a more localized level, such as the state level. The present study utilized the Florida Cancer Data System (FCDS) to investigate sociodemographic and geographical characteristics, as well as overall survival (OS), among patients diagnosed with laryngeal or hypopharyngeal SCC in Florida. This study enables the identification of specific areas where targeted public health initiatives can be established or strengthened.

Patient & Methods

This project was conducted in compliance with ethical principles, and was exempt from review, approval, or oversight by the University of Miami Miller School of Medicine Institutional Review Board (IRB). This retrospective cohort study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.¹⁰

Patient Selection

We established specific criteria for the selection of cases in our study based on data obtained from the FCDS, a de-identified comprehensive cancer registry encompassing all cancer diagnoses in Florida dating back to 1981.¹¹ Our inclusion criteria encompassed cases related to hypopharyngeal cancer (ICD codes C13.0–C13.9) and laryngeal cancer (ICD codes C32.0-C32.9). Additionally, we included cases with histological features consistent with squamous cell carcinoma (SCC) (ICD-O-3 codes 8050-8052, 8070-76, 8078, 8082-84) (Figure 1).¹²

Figure 1.

Flowchart of exclusion and inclusion criteria.

Predictor Variables

Variables collected by FCDS and included in our analysis were the following: age, sex, race, ethnicity, marital status, insurance status, cigarette tobacco smoking status, SEER 2010 stage of disease, zip code, census code, date of diagnosis, date of last contact, and mortality status at date of last contact.

Age at diagnosis was dichotomized into two groups: <60 years and ≥60 years. Self-identified race groups included Whites and Blacks. Other groups, including Native American, Asians and those of other Asian descent were excluded due to their small representation (1%–2%). Other factors included self-identified ethnicity (Hispanic or non-Hispanic), marital status at time of diagnosis (never married (single, unmarried, or domestic partner), previously married (separated, divorced, widowed), married (including common law)), SEER 2010 disease stage (in-situ, local, regional, distant, unstaged). Insurance status (uninsured, private insurance, public insurance (Medicaid, Medicare, TRICARE, Military, Veterans Affair, Indian/Public Health Service)) Tobacco cigarette smoking status was categorized as “never used”, “current user”, “former user”, or “unknown”. Florida counties were considered urban or rural based on the 2010 Census Bureau’s urban-rurality classification.

FCDS does not collect information on education and income, as such, we linked each patient’s census code to the American Community Survey (ACS) census bureau data to infer information about the patient’s education level (% with at least a bachelor’s degree) and income (median income in the last 12 months). For this study, we grouped these variables into quartiles.¹³

Additionally, we explored whether the lack of Medicaid expansion in Florida under the Affordable Care Act (ACA) in 2014 impacted OS. Therefore, we categorized patients diagnosed pre- (2010-2013) and post-ACA (2014-2017).^14,15

Statistical Analysis

All statistical analyses were performed with IBM SPSS Statistics, Version 28.0 (Armonk, NY). Associations between categorical variables were examined using chi-square tests. The primary outcome was overall survival (OS) defined as the time from date of diagnosis to date of death or last contact date. Survival curves and median survival were estimated by the Kaplan-Meier method. Log-rank test was used to determine if there was a statistically significant difference between OS curves. Univariable and multivariable cox proportional hazards regression models were used to assess predictors of OS, with results reported as unadjusted and adjusted hazard ratios (HRs) with 95% confidence intervals (95% CI). Kaplan-Meier survival plots were customized using the SAS V.9.4 (SAS Institute) NewSurv macro.¹⁶ ArcGIS maps were designed using ArcGIS Pro 3.0 software. A P value of <.05 was considered statistically significant. Data was analyzed from November 1, 2022, to June 30, 2023.

Results

Patient and Clinical Characteristics

Demographic and clinical characteristics of the cohort are outlined in Tables 1 and 2. The median age of the cohort at diagnosis was 66 years. Of the 6771 patients meeting selection criteria, the majority were at least 60 years of age at diagnosis (70.6%), male (81.2%), White non-Hispanic (WNH) (78.2%), publicly insured (70.1%), married (51.8%), and were former (39%) or current (32.2%) tobacco smokers. Patients primarily resided in urban counties (73.6%) and were diagnosed with laryngeal site disease (86.8%). The cohort’s median income was $44,558. A significant proportion of patients had early-stage disease (in-situ/local) at presentation (55.7%), and 88.5% received treatment after diagnosis.

Table 1.

Demographics and Other Characteristics of (N = 6771) Hypopharyngeal/Laryngeal Cancer patients Diagnosed From 2010-2017. Tests Were Adjusted for all Pairwise Comparisons Using the Bonferroni Correction.

	Total Subjects		White, Non-Hispanic		White, Hispanic		Black
	n	%	n	%	n	%	n	%	P value
Total Subjects	6771		5296	78.2	781	11.5	694	10.2
Age at diagnosis									<.001
<60	1988	29.4	1491	28.2	227	29.1	270	38.9
≥60	4783	70.6	3805	71.8	554	70.9	424	61.1
Sex									<.001
Male	5498	81.2	4233	79.9	678	86.8	587	84.6
Female	1273	18.8	1063	20.1	103	13.2	107	15.4
Marital status									<.001
Married	3505	51.8	2860	54.0	401	51.3	244	35.2
Single/unmarried	1623	24.0	1126	21.3	196	25.1	301	43.4
Separated/Divorced/Widowed	1643	24.3	1310	24.7	184	23.6	149	21.5
Insurance status									<.001
Private insurance	1607	23.7	1271	24.0	210	26.9	126	18.2
Public insurance	4745	70.1	3729	70.4	505	64.7	511	73.6
Uninsured	419	6.2	296	5.6	66	8.5	57	8.2
Cigarette (tobacco) smoking status									<.001
Never smoker	840	12.4	591	11.2	142	18.2	107	15.4
Current smoker	2183	32.2	1765	33.3	180	23.0	238	34.3
Former smoker	2644	39.0	2089	39.4	322	41.2	233	33.6
Unknown	1104	16.3	851	16.1	137	17.5	116	16.7
Median income									<.001
>56 957	1629	25.0	1461	27.6	154	19.7	77	11.1
44 559-56,957	1693	25.0	1421	26.8	168	21.5	104	15.0
35 001-44,558	1688	24.9	1367	25.8	160	20.5	161	23.2
0-35,000	1698	25.1	1047	19.8	299	38.3	352	50.7
Education (% with at least a bachelor's degree)									<.001
>32.6%	1689	24.9	1448	27.3	165	21.1	76	11.0
21.4-32.6	1661	24.5	1364	25.8	180	23.0	117	16.9
14-21.3	1726	25.5	1354	25.6	206	26.4	166	23.9
0-13.9	1695	25.0	1130	21.3	230	29.4	335	48.3
Geographic region									<.001
Urban	4986	73.6	3874	73.1	673	86.2	439	63.3
Rural	1785	26.4	1422	26.9	108	13.8	255	36.7
ACA Medicaid expansion									.347
Pre-expansion (2010-2013)	3313	48.9	2598	49.1	392	50.2	323	46.5
Post-expansion (2014-2017)	3458	51.1	2698	50.9	389	49.8	371	53.5
Tumor site									<.001
Larynx	5875	86.8	4574	86.4	723	92.6	578	83.3
Hypopharynx	896	13.2	722	13.6	58	7.4	116	16.7
SEER stage 2018									<.001
Early (in-situ/local)	3773	55.7	2996	56.6	461	59.0	316	45.5
Regional	1757	25.9	1383	26.1	174	22.3	200	28.8
Distant	1241	18.3	917	17.3	146	18.7	178	25.6
Treatment Status									.409
Yes	5990	88.5	4677	88.3	702	89.9	611	88.0
No	781	11.5	619	11.7	79	10.1	83	12.0

^aTests were adjusted for all pairwise comparisons using the Bonferroni correction.

Table 2.

Demographics and Other Characteristics of (N = 6771) Hypopharyngeal/Laryngeal Cancer patients Based on pre-vs Post-ACA Medicaid Expansion Period. Tests Were Adjusted for all Pairwise Comparisons Using the Bonferroni Correction.

	Total Subjects		Pre-ACA Medicaid Expansion (2010-2013)		Post-ACA Medicaid Expansion (2014-2017)
	n	%	n	%	n	%	P value
Total subjects	6771
Age at diagnosis							.016
<60	1988	29.4	1018	30.7	970	28.1
≥60	4783	70.6	2295	69.3	2488	71.9
Sex							.286
Male	5498	81.2	2673	80.7	2825	81.7
Female	1273	18.8	640	19.3	633	18.3
Race/Ethnicity							.347
White, non-Hispanic	5296	78.2	2598	78.4	2698	78.0
White, Hispanic	781	11.5	392	11.8	389	11.2
Black	694	10.2	323	9.7	371	10.7
Marital status							.387
Married	3505	51.8	1743	52.6	1762	51.0
Single/unmarried	1623	24.0	783	23.6	840	24.3
Separated/Divorced/Widowed	1643	24.3	787	23.8	856	24.8
Insurance status							.006
Private insurance	1607	23.7	753	22.7	854	24.7
Public insurance	4745	70.1	2327	70.2	2418	69.9
Uninsured	419	6.2	233	7.0	186	5.4
Cigarette (tobacco) smoking status							<.001
Never smoker	840	12.4	400	12.1	440	12.7
Current smoker	2183	32.2	1007	30.4	1176	34.0
Former smoker	2644	39.0	1106	33.4	1538	44.5
Unknown	1104	16.3	800	24.1	304	8.8
Median income							.088
>56 957	1629	25.0	807	24.4	885	25.6
44 559-56,957	1693	25.0	828	25.0	865	25.0
35 001-44,558	1688	24.9	869	26.2	819	23.7
0-35,000	1698	25.1	809	24.4	889	25.7
Education (% with at least a bachelor's degree)							.857
>32.6%	1689	24.9	816	24.6	873	25.2
21.4-32.6	1661	24.5	820	24.8	841	24.3
14-21.3	1726	25.5	855	25.8	871	25.2
0-13.9	1695	25.0	822	24.8	873	25.2
Geographic region							.105
Urban	4986	73.6	2469	74.5	2517	72.8
Rural	1785	26.4	844	25.5	941	27.2
Tumor site							.056
Larynx	5875	86.8	2848	86.0	3027	87.5
Hypopharynx	896	13.2	465	14.0	431	12.5
SEER stage 2018							<.001
Early (in-situ/local)	3773	55.7	1879	56.7	1894	54.8
Regional	1757	25.9	778	23.5	979	28.3
Distant	1241	18.3	656	19.8	585	16.9
Treatment Status							.008
Yes	5990	88.5	2896	87.4	3094	89.5
No	781	11.5	417	12.6	364	10.5

Compared to WNH and White Hispanics (WH), Black patients were more likely to be older, single/unmarried (43.4%) and come from census tracts within Florida with lower median household incomes (50.7%) and education (48.3%) and were more likely to have distant SEER stage disease (25.6%). Black (8.2%) and WH (8.5%) patients were more likely than WNH (5.6%) to be uninsured. Black (16.7%) and WNH patients (13.6%) were more likely than WH (7.4%) to be diagnosed with hypopharyngeal SCC. There was no significant difference in treatment rates based on race/ethnicity (P = .409).

Fewer patients were uninsured (5.4% vs 7%, P = .006) and diagnosed with distant SEER stage disease post-vs pre-ACA Medicaid expansion (19.8% vs 16.9%, P < .001). Additionally, patients were more likely to have received treatment post-vs pre-expansion (89.5% vs 87.4, P = .008) (Table 2).

Median Survival Times

There were 3787 (55.9%) deaths at last contact. Overall median survival time (MST) was 42 months. Figure 2 displays the Kaplan Meier survival curves and MST for each factor. Black patients had the lowest MST, followed by WNH and WH (33 vs 41 vs 66 months, P < .001). Married patients had a higher MST than single/unmarried and previously married patients (55 vs 31 vs 33 months, P < .001). Privately insured patients had a higher MST than publicly insured and uninsured patients (65 vs 37 vs 34 months, P < .001). Patients with no tobacco smoking history had a significantly longer MST than current smokers and former smokers (63 vs 34 vs 46 months, P < .001). Patients from census tracts with the highest income (>$56,957) (54 months) and highest education (>32.6% with at least a bachelor’s degree) (57 months) had the longest MST (P < .001).

Figure 2.

Kaplan Meier curves of overall survival (OS) by A) age B) race/ethnicity C) sex D) marital status E) insurance status F) smoking status G) median income H) education I) geographical location J) pre-vs. post ACA Medicaid period K) cancer site L) SEER disease stage, and N) treatment status.

Cox Regression Analysis

Univariable and multivariable Cox proportional hazards regression models were fitted to OS in Table 3. In univariable analysis, we found the following factors to be predictors of significantly lower OS: Black race/ethnicity (HR 1.21 [95%CI: 1.090-1.337], P < .001), single/unmarried (HR 1.47 [95%CI: 1.36-1.59], P < .001) or previously married status (HR 1.46 [95%CI: 1.348-1.571], P < .001), public insurance (HR 1.66 [95%CI: 1.525-1.810], P < .001) or uninsured status (HR 1.66 [95%CI: 1.433-1.927, P < .001), current smokers (HR 1.62 [95%CI: 1.440-1.817], P < .001), former smokers: (HR 1.28 [95%CI: 1.139-1.437], P < .001), lower median household income ($0-35,000: HR 1.41 [95%CI: 1.284-1.544], P < .001), lower education (0%–13.9%: HR 1.45 [95%CI: 1.321-1.585], P < .001), rural county residence (HR 1.08 [95%CI: 1.008-1.164], P = .03), diagnosis post-ACA implementation (HR 1.19 [95%CI: 1.108-1.267], P < .001), hypopharyngeal SCC (HR 1.84 [95%CI: 1.695-2.003], P < .001), regional (HR 1.80 [95%CI: 1.672-1.940], P < .001) or distant (HR 2.30 [95%CI: 2.124-2.497], P < .001) stage disease and untreated status (HR 1.82 [95%CI: 1.659-1.985], P < .001). Interestingly, WH had a significantly higher OS compared to WNH (HR .73 [95%CI: .655-.817], P < .001). Female patients had a similar OS compared to males (P = .298).

Table 3.

Univariable and multivariable Cox Regression Models Assessing Predictors of overall survival (OS) (N = 6771: 3787 died, 2984 Alive).

	Univariable Models				Multivariable Models
	HR^a	95% CI		P value	HR	95% CI		P value
Age at diagnosis
<60	1 (Ref)				1 (Ref)
≥60	1.11	1.032	1.191	.005	1.24	1.146	1.347	<.001
Sex
Male	1 (Ref)				1 (Ref)
Female	.96	.883	1.039	.298	.88	.807	.954	.002
Race/Ethnicity
White, non-Hispanic	1 (Ref)				1 (Ref)
White, Hispanic	.73	.655	.817	<.001	.75	.672	.842	<.001
Black	1.21	1.09	1.337	<.001	.98	.881	1.092	.723
Marital status
Married	1 (Ref)				1 (Ref)
Single/unmarried	1.47	1.36	1.59	<.001	1.24	1.139	1.345	<.001
Separated/Divorced/Widowed	1.46	1.348	1.571	<.001	1.24	1.15	1.346	<.001
Insurance status
Private insurance	1 (Ref)				1 (Ref)
Public insurance	1.66	1.525	1.81	<.001	1.50	1.374	1.645	<.001
Uninsured	1.66	1.433	1.927	<.001	1.33	1.144	1.549	<.001
Cigarette (tobacco) smoking status
Never smoker	1 (Ref)				1 (Ref)
Current smoker	1.62	1.44	1.817	<.001	1.41	1.254	1.591	<.001
Former smoker	1.28	1.139	1.437	<.001	1.20	1.07	1.353	.002
Unknown	1.30	1.145	1.476	<.001	1.18	1.035	1.34	.013
Median income
>56 957	1 (Ref)				1 (Ref)
44 559-56,957	1.19	1.082	1.306	<.001	1.08	.974	1.206	.14
35 001-44,558	1.33	1.215	1.461	<.001	1.13	1.008	1.271	.036
0-35,000	1.41	1.284	1.544	<.001	1.08	.953	1.229	.225
Education (% with at least a bachelor's degree)
>32.6%	1 (Ref)				1 (Ref)
21.4-32.6	1.22	1.112	1.34	<.001	1.12	1.006	1.239	.038
14-21.3	1.26	1.153	1.387	<.001	1.12	.993	1.251	.065
0-13.9	1.45	1.321	1.585	<.001	1.20	1.061	1.364	.004
Geographic region
Urban	1 (Ref)				1 (Ref)
Rural	1.08	1.008	1.164	.03	1.02	.944	1.092	.683
ACA
Pre-ACA (2010-2013)	1 (Ref)				1 (Ref)
Post-ACA (2014-2017)	1.19	1.108	1.267	<.001	1.17	1.09	1.252	<.001
Tumor site
Larynx	1 (Ref)				1 (Ref)
Hypopharynx	1.84	1.695	2.003	<.001	1.48	1.359	1.619	<.001
SEER stage
Early (in-situ/local)	1 (Ref)				1 (Ref)
Regional	1.80	1.672	1.94	<.001	1.73	1.601	1.877	<.001
Distant	2.30	2.124	2.497	<.001	2.19	2.013	2.392	<.001
Treatment Status
Yes	1 (Ref)				1 (Ref)
No	1.82	1.659	1.985	<.001	2.11	1.924	2.314	<.001

HR (95% CI): hazard ratio and corresponding 95% confidence interval.

^bP: P value from Wald test for H₀: HR = 1 (same risk in both groups). Bold indicates results statistically significant at P < .05.

In multivariable analysis, while controlling for all the covariates in Tables 1 and 2, worse OS was maintained among older patients (≥60 y), single/married or previously married, publicly insured, uninsured, history of tobacco smoking, diagnosis post-Medicaid expansion, hypopharyngeal SCC, regional or distant disease, and untreated; improved OS was maintained for WH vs WNH. Female patients (aHR .88 [95%CI: .807-.954], P = .002) had higher OS than males. Statistically significant results for Black race/ethnicity (P = .723) and rural county location (P = .683) were not upheld in the multivariable model.

Geospatial Mapping Analysis

At the census tract level, we observed mortality rates for hypopharyngeal and laryngeal SCC were highest in Northern Florida. Additionally, we observed the highest mortality rates in areas of Florida characterized by lower income and education levels (Figure 3).

Figure 3.

Median household income and education by census tract in the state of Florida, 2010-2017. The state is colored by median income and education, respectively. Circle size is proportional to the amount of mortality for each census tract.

Discussion

Our analysis revealed that age, sex, race/ethnicity, marital status, tobacco smoking status, insurance type, education, income, geographical location, stage of disease, and treatment status were associated with OS from hypopharyngeal/laryngeal SCC in Florida. While previous studies explored the impact of these factors related to laryngeal cancer outcomes such as treatment approaches, disease stage at presentation, and survival status,⁶ there is limited literature discussing such disparities at a more localized level.^17–19

Blacks had lower MST and OS than WH and WNH in univariable analysis. However, multivariate analysis showed similar OS rates for Black and WNH patients, contradicting many studies showing racial disparities in laryngeal cancer OS,^13,20–25 and aligning with few that have found no significant difference.^26,27 There are several reasons to have suspected that Blacks would have had lower OS than Whites. Black patients often have larger tumors, more advanced disease at presentation, and differences in treatment rates.^13,20,28,29 Additionally, non-white patients are more likely to experience treatment delays.^30,31 In our study, Black and WNH patients had similar treatment rates. However, Black patients were more likely to be single, younger, less educated, poorer, and be uninsured at presentation. These factors likely worsened OS; however, it is unknown whether other unstudied factors might explain the lack of racial disparities in OS between Blacks and WNH.

The "Hispanic paradox" has been observed in other HNC cancers, where WH have better survival than WNH.³² In our study, WH made up 11.5% of the cohort and had improved OS compared to WNH in univariable and multivariable Cox regression models. We hypothesize that the survival benefit in our cohort is linked to smoking habits and early-stage diagnosis in WH patients. WH patients in our study were less likely to be current smokers and more likely to be diagnosed with early (in-situ/local) SEER stage disease at presentation. Further research is needed to identify the drivers of this benefit, especially among Hispanic subgroups. It would be worth investigating if this relationship holds in heavily WH areas, like Miami-Dade County, Florida.

Our study also revealed significant differences in OS based on gender. Multivariable cox regression analysis showed that females with hypopharyngeal/laryngeal SCC had higher OS compared to males, similar to previous studies.^{13,19,21–23,33} However, one study observed lower OS in females with laryngeal cancer,³¹ suggesting some slight variation in the gender disparity. Lower OS among males is typically attributed to their higher tobacco and alcohol consumption, both behaviors that confer a higher risk of developing HNC,³⁴ especially when used together.³⁵

We found that uninsured or publicly insured patients had worse OS than those with private insurance, which aligns with previous studies.^21,29,36 Chen and Halpern et al²¹ conducted a retrospective review of 7019 advanced laryngeal SCC patients, and showed that uninsured and Medicaid patients had lower OS compared to privately insured patients. Mehta et al²⁹ found that at every stage of laryngeal cancer, uninsured patients had lower OS than those privately insured, and Medicare patients had higher OS than those who were uninsured. Insurance status is important to examine in the context of cancer disparities as public insurance/no insurance status may limit patients’ access to adequate medical care and delayed care due to costs.³¹ For instance, a previous study found that HNSCC patients with Medicare/Medicaid insurance were less likely to receive adjuvant therapy.³⁷

Florida is a good example to study cancer disparities considering it is among the few states that declined Medicaid expansion. Several previous studies have analyzed the impact of Medicaid expansion on HNC patients.^14,15,38,39 Cannon et al¹⁵ found fewer HNSCC patients were uninsured post-Medicaid expansion than pre-expansion. However, they found this difference to be negligible in Medicaid non-expansion states. Patel et al¹⁴ found that Medicaid expansion states had lower proportions of uninsured HNC patients with advanced stage (T4 and N2c) than non-expansion states, but this difference was insignificant when assessing overall stage (I-IV). We observed a slight decrease in distant SEER stage hypopharyngeal/laryngeal cancer post-expansion. Interestingly, a diagnosis of hypopharyngeal/laryngeal SCC post-Medicaid expansion was linked to poorer OS. The cause of this is unknown and needs further study. Future studies should compare states based on Medicaid expansion to better understand the effect of health care policies on hypopharyngeal/laryngeal SCC survival.

Our study showed that married individuals at diagnosis had higher overall survival than single/unmarried or previously married people, which is consistent with other studies.^13,40–43 A previous study found that unmarried persons with oral and laryngeal cancer were more likely to have metastatic disease.⁴³ Unmarried people may have worse outcomes due to lack of emotional and financial support, and the relationship between stress, depression, and tumor growth, response, and regression through inflammatory markers and stress hormones.^44,45 Marital status may also affect treatment selection, with one study showing that married patients with laryngeal cancer were more likely to receive definitive treatment.⁴³

We investigated the impact of rural-urban geography on mortality rates for laryngeal and hypopharyngeal cancer and found OS to be lower among rural county dwellers in the univariable cox regression model, but not maintained after adjusting for co-variables. Zuniga and Lango et al⁴⁶ and Kim et al⁴⁷ did not observe significant differences in laryngeal cancer 5-year survival rates based on geography. In contrast, Misono et al²⁴ observed lower OS among patients treated at rural hospitals for incident T1 glottic SCC. Ravikumar et al¹⁷ found lower OS among patients in small rural towns in New York compared to urban areas. The higher mortality rates in rural communities might be attributed to limited financial resources and access to health care facilities. Future studies would benefit from exploring the impact of distance to care on OS.

This retrospective study has certain limitations. As with other database studies, the accuracy and consistency of the collected patient data may be subject to inaccuracies and inconsistencies. Information, such as tobacco behavior, relies on self-reporting and may be susceptible to bias. The FCDS database does not collect data on the quantity of tobacco smoked or alcohol consumed, both are relevant factors considering the dose-response relationship between alcohol/tobacco use and cancer risk. Additionally, median income and education are derived from census data from the U.S Census Bureau, which may not be as accurate as collecting direct data from patients. An additional limitation in our analysis is the choice of staging system. Our study defined early disease (in-situ and local) using the SEER staging system, which is the default system in the FCDS database. With over 50% of patients in our cohort exhibiting "early stage" disease, SEER stage may not offer as much detailed information about the extent of the cancer as offered by the T classification in the TNM system, which may limit the precision of our study. Despite these limitations, we have confidence in the reliability of this study’s findings as it presents a comprehensive representation of the Florida population.

Conclusion

Our study identified sex, race/ethnicity, geographical location, marital status, insurance status, education, income, pre-vs post-ACA Medicaid expansion, disease stage, tobacco smoking status and treatment status as predictors of lower OS from hypopharyngeal/laryngeal SCC. Our geographical mapping analysis emphasized the impact of education and income on OS from this disease in Florida.

In essence, our research offers crucial insights for a range of stakeholders, such as policymakers, community organizations, health care professionals, and researchers, specifically in Florida. Our mapping analysis is instrumental in pinpointing areas within the state where it is crucial to prioritize head and neck screening initiatives and allocate resources for prevention programs. Furthermore, our data supports the initiation of health education campaigns addressing alcohol and tobacco abuse, as well as the prevention and early detection of head and neck cancers in Florida’s hotspots where the morality rates from head and neck cancer are disproportionately high. Additionally, this information may act as a catalyst for the development of new policy initiatives aimed at reducing mortality from hypopharyngeal/laryngeal cancer post-diagnosis. This may include measures such as Medicaid expansion, the provision of psychosocial support services for cancer patients, and increased funding for access to cancer care in underserved regions within Florida.

Our future research will aim to analyze risk factors at the neighborhood level in specific areas of Florida, such as Miami-Dade County, with the goal of providing more targeted guidance for public health interventions.

Footnotes

Author Contributions

UE and EF devised the project, the main conceptual ideas, and research question. UE, IR analyzed the data. UE wrote the paper with input from all authors. AA, IB, ML, GF, SP, AD, LS, DW, EK, IR, EF provided input and edits on the final draft of the study.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Ethical Statement

ORCID iDs

Uche C Ezeh

Isabella Buitron

References

Siegel

Miller

Wagle

Jemal

. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi:10.3322/caac.21763

Mendenhall

Werning

Pfister

. Treatment of head and neck cancers. In: DeVita

, ed. Rosenberg’s Cancer: Principles and Practice of Oncology. Lippincott Williams & Wilkins; 2011:729-780.

Takes

Strojan

Silver

, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. In: Eisele

, ed.,Head Neck. 2012;34(2):270-281. doi:10.1002/hed.21613

Dong

Cioffi

Wang

, et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1389-1397. doi:10.1158/1055-9965.EPI-20-0036

Survival rates for laryngeal and hypopharyngeal cancers. American Cancer Society. Accessed February 19, 2023. https://www.cancer.org/cancer/laryngeal-and-hypopharyngeal-cancer/detection-diagnosis-staging/survival-rates.html

Feit

Wang

Demetres

Drenis

Andreadis

Rameau

. Healthcare disparities in laryngology: a scoping review. Laryngoscope. 2022;132(2):375-390. doi:10.1002/lary.29325

Divakar

Davies

. Trends in incidence and mortality of larynx cancer in the US. JAMA Otolaryngol Head Neck Surg. 2023;149(1):34-41. doi:10.1001/jamaoto.2022.3636

Mokdad

Dwyer-Lindgren

Fitzmaurice

, et al. Trends and patterns of disparities in cancer mortality among US counties, 1980-2014. JAMA. 2017;317(4):388-406. doi:10.1001/jama.2016.20324

Ludwig

Morrison

Dillon

. The Burden of head and neck cancer in the United States, 1990 - 2017. J Oral Maxillofac Surg. 2021;79(10):2162-2170. doi:10.1016/j.joms.2021.04.031

10.

von Elm

Altman

Egger

, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349. doi:10.1016/j.jclinepi.2007.11.008

11.

Florida cancer data system (FCDS). Accessed August 20, 2022. https://fcds.med.miami.edu/inc/welcome.shtml

12.

World Health Organization . International classification of diseases for Oncology (ICD-O) 1st Revision. 3rd ed. World Health Organization; 2013. Florida Cancer Data System. https://apps.who.int/iris/handle/10665/96612. Accessed 19 February 2023.

13.

Chen

Dee

Muralidhar

Nguyen

Amin

Givi

. Disparities in mortality from larynx cancer: Implications for reducing racial differences. Laryngoscope. 2021;131(4):E1147-E1155. doi:10.1002/lary.29046

14.

Patel

Shabani

Padhya

, et al. The impact of the affordable care act on insurance coverage and stage among head and neck squamous cell carcinoma patients. J Health Care Poor Underserved. 2022;33(3):1322-1336. doi:10.1353/hpu.2022.0115

15.

Cannon

Shepherd

McCrary

, et al. Association of the patient protection and affordable care act with insurance coverage for head and neck cancer in the SEER database. JAMA Otolaryngol Head Neck Surg. 2018;144(11):1052-1057. doi:10.1001/jamaoto.2018.1792

16.

Meyers

The %NEWSURV Family of Macros: An Update on the Survival Plotting Macro %NEWSURV and an Introduction to Expansion Macros. Rochester, Minnesota: PharmaSUG.

17.

Ravikumar

Casellas

Shah

Rieth

. Geographic disparities in head and neck cancer survival in Upstate New York 2011–2019. Head Neck. 2022;44(2):472-482. doi:10.1002/hed.26945

18.

Mourad

Dezube

Moshier

Shin

. Geographic trends in management of early-stage laryngeal cancer: trends in laryngeal cancer management. Laryngoscope. 2016;126(4):880-884. doi:10.1002/lary.25768

19.

Cuchiara

Asal

. Laryngeal neoplasm mortality in Oklahoma: 1950–1970. South Med J. 1976;69(7):908-910. doi:10.1097/00007611-197607000-00033

20.

Shin

Truong

. Racial disparities in laryngeal cancer treatment and outcome: a population-based analysis of 24,069 patients. Laryngoscope. 2015;125(7):1667-1674. doi:10.1002/lary.25212

21.

Chen

Halpern

. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007;133(12):1270-1276. doi:10.1001/archotol.133.12.1270

22.

Saini

Genden

Megwalu

. Sociodemographic disparities in choice of therapy and survival in advanced laryngeal cancer. Am J Otolaryngol. 2016;37(2):65-69. doi:10.1016/j.amjoto.2015.10.004

23.

Kejner

. Treatment modality and outcomes in larynx cancer patients: a sex‐based evaluation. Head Neck. 2019;41(11):3764-3774. doi:10.1002/hed.25897

24.

Misono

Marmor

Yueh

Virnig

. T1 glottic carcinoma: do comorbidities, facility characteristics, and sociodemographics explain survival differences across treatment types? Otolaryngol Head Neck Surg. 2015;152(5):856-862. doi:10.1177/0194599815572112

25.

Wasfie

Newman

. Laryngeal carcinoma in black patients. Cancer. 1988;61(1):167-172. doi:10.1002/1097-0142(19880101)61:1<167::aid-cncr2820610128>3.0.co;2-h

26.

Roach

Alexander

Coleman

. The prognostic significance of race and survival from laryngeal carcinoma. J Natl Med Assoc. 1992;84(8):668-674.

27.

Zakeri

MacEwan

Vazirnia

, et al. Race and competing mortality in advanced head and neck cancer. Oral Oncol. 2014;50(1):40-44. doi:10.1016/j.oraloncology.2013.09.012

28.

Chen

Schrag

Halpern

Stewart

Ward

. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg. 2007;133(8):784-790. doi:10.1001/archotol.133.8.784

29.

Mehta

Shi

Mills

Nathan

CAO

Shi

. Effect of payer status on relative survival of patients with laryngeal cancer. Anticancer Res. 2016;36(1):327-333.

30.

Massa

Osazuwa-Peters

Franco

Ward

Walker

. Survival after refusal of surgical treatment for locally advanced laryngeal cancer. Oral Oncol. 2017;71:34-40. doi:10.1016/j.oraloncology.2017.05.019

31.

Morse

Fujiwara

RJT

Judson

Mehra

. Treatment delays in laryngeal squamous cell carcinoma: a national cancer database analysis. Laryngoscope. 2018;128(12):2751-2758. doi:10.1002/lary.27247

32.

Parasher

Abramowitz

Weed

, et al. Ethnicity and clinical outcomes in head and neck cancer: an analysis of the SEER database. J Racial and Ethnic Health Disparities. 2014;1(4):267-274. doi:10.1007/s40615-014-0033-3

33.

Jayakrishnan

White

Greenberg

Colonias

Wegner

. Predictors of chemotherapy and its effects in early stage squamous cell carcinoma of the larynx. Laryngoscope Investig Otolaryngol. 2020;5(3):445-452. doi:10.1002/lio2.327

34.

Hashibe

Boffetta

Zaridze

, et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol. 2007;165(7):814-820. doi:10.1093/aje/kwk066

35.

Talamini

Bosetti

La Vecchia

, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 2002;13(10):957-964. doi:10.1023/a:1021944123914

36.

Stephen

Chen

Shah

, et al. Human papillomavirus outcomes in an access‐to‐care laryngeal cancer cohort. Otolaryngol Head Neck Surg. 2012;146(5):730-738. doi:10.1177/0194599811434482

37.

Chen

Roman

Yarbrough

Burtness

Sosa

Judson

. Trends and variations in the use of adjuvant therapy for patients with head and neck cancer: adjuvant therapy for head and neck cancer. Cancer. 2014;120(21):3353-3360. doi:10.1002/cncr.28870

38.

Panth

Barnes

Sethi

RKV

Varvares

Osazuwa-Peters

. Socioeconomic and demographic variation in insurance coverage among patients with head and neck cancer after the affordable care act. JAMA Otolaryngol Head Neck Surg. 2019;145(12):1144-1149. doi:10.1001/jamaoto.2019.2724

39.

Sineshaw

Ellis

Yabroff

, et al. Association of medicaid expansion under the affordable care act with stage at diagnosis and time to treatment initiation for patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2020;146(3):247-255. doi:10.1001/jamaoto.2019.4310

40.

Elwood

Pearson

JCG

Skippen

Jackson

. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer. 1984;34(5):603-612. doi:10.1002/ijc.2910340504

41.

Ding

. Effects of marital status on overall and cancer-specific survival in laryngeal cancer patients: a population-based study. Sci Rep. 2021;11(1):723. doi:10.1038/s41598-020-80698-z

42.

Zhan

, et al. Marital status and survival in laryngeal squamous cell carcinoma patients: a multinomial propensity scores matched study. Eur Arch Oto-Rhino-Laryngol. 2022;279(6):3005-3011. doi:10.1007/s00405-022-07252-7

43.

Inverso

Mahal

Aizer

Donoff

Chau

Haddad

. Marital status and head and neck cancer outcomes. Cancer. 2015;121(8):1273-1278. doi:10.1002/cncr.29171

44.

Pike

Irwin

. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun. 2006;20(2):169-174. doi:10.1016/j.bbi.2005.05.004

45.

Antoni

Lutgendorf

Cole

, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006;6(3):240-248. doi:10.1038/nrc1820

46.

Zuniga

Lango

. Effect of rural and urban geography on larynx cancer incidence and survival. Laryngoscope. 2018;128(8):1874-1880. doi:10.1002/lary.27042

47.

Kim

Firouzbakht

Ruan

, et al. Urban and rural differences in outcomes of head and neck cancer: urban vs. Rural head and neck cancer survival. Laryngoscope. 2018;128(4):852-858. doi:10.1002/lary.26836

Investigating Disparities in Hypopharyngeal/Laryngeal Cancer Survival in Florida With Geospatial Mapping Analysis

Abstract

Objective

Material and Methods

Results

Conclusion

Keywords

Introduction

Patient & Methods

Patient Selection

Predictor Variables

Statistical Analysis

Results

Patient and Clinical Characteristics

Median Survival Times

Cox Regression Analysis

Geospatial Mapping Analysis

Discussion

Conclusion

Footnotes

Author Contributions

Declaration of Conflicting Interests

Funding

Ethical Statement

ORCID iDs

References